Molecular and cellular basis of cannabinoid and opioid interactions.
about
The endocannabinoid system as an emerging target of pharmacotherapy15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuseCannabinoid and opioid interactions: implications for opiate dependence and withdrawalA pilot trial of low-dose naltrexone in primary progressive multiple sclerosisThe subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for painCannabinoid-opioid interactions during neuropathic pain and analgesia.Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter SurveyCannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?The pleasures of play: pharmacological insights into social reward mechanismsShort-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerolImpact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice.Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies.Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.Colitis generates remote antinociception in rats: the role of the L-arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Neural Circuit in the Dorsal Raphe Nucleus Responsible for Cannabinoid-Mediated Increases in 5-HT Efflux in the Nucleus Accumbens of the Rat BrainHigh motivation for exercise is associated with altered chromatin regulators of monoamine receptor gene expression in the striatum of selectively bred mice.Microinjection of WIN55,212-2 as A Cannabinoid Agonist into The Basolateral Amygdala Induces Sensitization to Morphine in RatsEndocannabinoid system involvement in brain reward processes related to drug abuseThe Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of RatImpact of cannabis use during stabilization on methadone maintenance treatmentEffects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.The endocannabinoid system in brain reward processesInteractions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex.Role of endocannabinoids in regulating drug dependence.The endocannabinoid system: emotion, learning and addiction.Receptor and channel heteromers as pain targets.Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance.Trajectory of adolescent cannabis use on addiction vulnerability.Shared mechanisms of alcohol and other drugs.Interaction of the cannabinoid and opioid systems in the modulation of nociception.Combining rimonabant and fentanyl in a single entity: preparation and pharmacological resultsSignal transduction via cannabinoid receptors.
P2860
Q24648473-0945B9E4-18CE-471C-879E-CC3880813A49Q26824667-77BDC654-1AD6-41B5-B89B-88C5CDA14EF1Q27000762-58B237C6-F865-4C3F-B780-A4671122F2DFQ28291875-5DE6ED09-B3B4-4BE9-AA18-DA9D846F1624Q33578856-C6519BA1-C58F-49A9-9832-5535049B0252Q33637224-69AE1710-C32F-40F8-8DF5-E86F3B5F4D8FQ33708526-CD0C6CBD-3B01-4C47-A021-9BEA07367F6BQ33715462-FC1DFAA4-02E3-4C70-A2D5-3CACC18F4615Q34077887-CAD1DEBF-0A50-4F13-8645-66A33853389DQ34098179-4F9DEFD7-C54B-4118-8738-9232780ED4C6Q34159109-15756915-D6E8-4F72-B7F7-5BB56FEC5C84Q34254854-D26A11B2-2C70-48D0-B761-A108A4D411DAQ34360705-7BC7D6CD-7FCC-4B01-98A9-AFECC6F2F935Q34674584-F4373267-A396-4604-9DF7-8FB29F66EBD8Q34973799-99196BA6-61B8-4124-B527-A51D276C8B85Q35053193-4F5D38DD-2C8A-46FC-98BD-A3029A3656A7Q35193322-05A3AA59-968E-4169-A256-0407C00EC441Q35305940-BE39930B-6B77-4AC2-BA31-6626F30673A0Q35532072-7024F1C4-191B-4EC7-88EF-FA45D287B1C0Q36102335-03F35C13-EBA9-4E5C-9465-5AE729BC15B4Q36165004-57B411B0-84CB-42F2-BE05-8E509E87FBFDQ36309904-7B50A667-83A1-491A-A64E-47CF1E4FD268Q36357182-A30F376B-0046-4657-B674-C8FA99528CFDQ36358395-85A461BE-7A80-40DD-9B8D-E1718CE1C167Q36476801-403E0FA8-1F1A-4300-A547-094FEDCA226AQ36655914-9A4FE8E9-2A77-4C22-8051-E4C670A7BCD3Q36741861-73910D8E-8C89-41FD-9C7A-ABE0DCCDC26AQ36852576-8ADC9E1D-D17E-4093-AD35-DE10119F1FCDQ36977483-F212E1AC-6506-456C-807E-94EFF64F514BQ37003653-2CBCBFBA-1986-4842-A6C7-D3765305BBECQ37129779-67427792-0765-4607-9308-EF3C25ABEF01Q37142237-E136CFBC-9242-4E00-967A-68B04CEA9287Q37148710-CCDB471A-9AA5-4996-8D0D-0D8366F4E458Q37266063-E33C11FA-8D73-479B-810B-8C097C5E19C0Q37360643-82D77240-89E9-4589-AE3F-1868492C90DEQ37381132-4B31216A-0BE7-41CC-AD73-7E3512C807FEQ37386501-A30EDEA5-1CA6-41A5-89E2-26C982D23991Q37444813-FE1DB6E0-56DF-4A94-9851-1F2D10D657FAQ37602963-24EF11BE-B1C9-4635-8944-8F3F44266164Q37617453-084BA035-A9F0-4D35-9542-D331162725DA
P2860
Molecular and cellular basis of cannabinoid and opioid interactions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular and cellular basis of cannabinoid and opioid interactions.
@ast
Molecular and cellular basis of cannabinoid and opioid interactions.
@en
type
label
Molecular and cellular basis of cannabinoid and opioid interactions.
@ast
Molecular and cellular basis of cannabinoid and opioid interactions.
@en
prefLabel
Molecular and cellular basis of cannabinoid and opioid interactions.
@ast
Molecular and cellular basis of cannabinoid and opioid interactions.
@en
P1476
Molecular and cellular basis of cannabinoid and opioid interactions
@en
P2093
Daniela Parolaro
Daniela Viganò
P304
P356
10.1016/J.PBB.2005.01.021
P407
P577
2005-06-01T00:00:00Z